Epidemiological Features of the Incidence of COVID-19 in Moscow in the Period from March 1 to August 31, 2020
https://doi.org/10.35627/2219-5238/2021-336-3-57-62
Abstract
Introduction. Coronavirus (SARS-CoV-2) infection is a global healthcare and social problem due to a rapid ubiquitous spread of the virus, a high rate of complications and deaths. The disease is often asymptomatic, which can contribute to its spread, while the most common complication is the development of pneumonia with or without acute respiratory failure and respiratory distress syndrome, which are often fatal. These characteristics of the disease, along with the almost complete lack of immunity in the population around the world (before the mass spread), allowed SARS-CoV-2 to spread freely among the population of all countries. Our objective was to assess the epidemiological features of the incidence of the novel coronavirus disease (COVID-19) in the population of the city of Moscow.
Materials and methods. We conducted a retrospective analysis of all confirmed COVID-19 cases, the total number of diagnostic tests for COVID-19, and the incidence of upper respiratory tract infections registered in Moscow from March 1 to August 31, 2020. The correlation analysis was performed by calculating the Spearman’s correlation coefficient and subsequent statistical significance of differences in the compared relative values (p) from the Student’s t-test. Confidence intervals were determined with the calculation of average errors of the compared variables – m(σ).
Conclusion. The revealed features of the COVID-19 incidence in Moscow help establish the factors influencing the development of the epidemic process in the city and give an accurate prediction of the COVID-19 situation for the future.
About the Authors
A. V. IvanenkoRussian Federation
Alexander V. Ivanenko, D.M.Sci., Professor, Chief Physician
Bldgs 2,3,4, 4 Grafsky Lane, Moscow, 129626
D. V. Soloviev
Russian Federation
Dmitry V. Soloviev, Candidate of Medical Sciences, Head, Anti-Epidemic Division
Bldgs 2,3,4, 4 Grafsky Lane, Moscow, 129626
N. A. Volkova
Russian Federation
Natalya A. Volkova, Head, Department of Epidemiology
Bldgs 2,3,4, 4 Grafsky Lane, Moscow, 129626
V. M. Glinenko
Russian Federation
Victor M. Glinenko, D.M.Sc., Professor, Deputy Chief Physician
Bldgs 2,3,4, 4 Grafsky Lane, Moscow, 129626
O. A. Smirnova
Russian Federation
Olga A. Smirnova, Epidemiologist, Anti-Epidemic Division
Bldgs 2,3,4, 4 Grafsky Lane, Moscow, 129626
I. S. Shvedova
Russian Federation
Irina S. Shvedova, Epidemiologist, Anti-Epidemic Division
Bldgs 2,3,4, 4 Grafsky Lane, Moscow, 129626
E. V. Bakhmutskaya
Russian Federation
Elena V. Bakhmutskaya, Epidemiologist, Anti-Epidemic Division
Bldgs 2,3,4, 4 Grafsky Lane, Moscow, 129626
D. A. Melnikov
Russian Federation
Dmitry A. Melnikov, Epidemiologist, Anti-Epidemic Division
Bldgs 2,3,4, 4 Grafsky Lane, Moscow, 129626
References
1. Vorobyeva OV, Lastochkin AV. A clinical and morphological case of COVID-19. Epidemiologiya i Infektsionnye Bolezni. Aktual’nye Voprosy. 2020; 10(2):90–93. (In Russian). DOI: https://dx.doi.org/10.18565/epidem.2020.2.90-93
2. Briko NI, Kagramanyan IN, Nikiforov VV, et al. Pandemic COVID-19. Prevention measures in the Russian Federation. Epidemiologiya i Vaktsinoprofilaktika. 2020; 19(2):4–12. (In Russian). DOI: https://doi.org/10.31631/2073-3046-2020-19-2-4-12
3. Kobayashi T, Jung SM, Linton NM, et al. Communicating the risk of death from novel coronavirus disease (COVID-19). J Сlin Med. 2020; 9(2):580. DOI: https://doi.org/10.3390/jcm9020580
4. Hu Z, Song C, Xu C, et al. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Sci China Life Sci. 2020; 63(5):706–711. DOI: https://doi.org/10.1007/s11427-020-1661-4
5. Liu K, Chen Y, Lin R, et al. Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients. J Infect. 2020;80(6):e14-e18. DOI: https://doi.org/10.1016/j.jinf.2020.03.005.
6. Ceccarelli M, Berretta M, Rullo E, et al. Differences and similarities between Severe Acute Respiratory Syndrome (SARS) – CoronaVirus (CoV) and SARS-CoV-2. Would a rose by another name smell as sweet? Eur Rev Med Pharmacol Sci. 2020; 24(5):2781–2783. DOI: https://doi.org/10.26355/eurrev_202003_20551
7. Rothe C, Schunk M, Sothmann P, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020; 382(10):970–971. DOI: https://doi.org/10.1056/NEJMc2001468
8. Abdollahi E, Champredon D, Langley JM, et al. Temporal estimates of case–fatality rate for COVID-19 outbreaks in Canada and the United States. CMAJ. 2020; 192(25):E666–E670. DOI: https://doi.org/10.1503/cmaj.200711
9. Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020; 579(7798):265–269. DOI: https://doi.org/10.1038/s41586-020-2008-3
10. Lvov DK, Alkhovsky SV, Kolobukhina LV, et al. Etiology of epidemic outbreaks COVID-19 in Wuhan, Hubei Province, Chinese People Republic associated with 2019-nCoV (Nidovirales, Coronaviridae, Coronavirinae, Betacoronavirus, Subgenus Sarbecovirus): lessons of SARS-CoV outbreak. Voprosy Virusologii. 2020; 65(1):6–15. (In Russian). DOI: https://doi.org/10.36233/0507-4088-2020-65-1-6-15
11. Shen M, Peng Z, Xiao Y, et al. Modeling the epidemic trend of the 2019 novel coronavirus outbreak in China. Innovation (N Y). 2020; 1(3):100048. DOI: https://doi.org/10.1016/j.xinn.2020.100048
12. Flahault A. COVID-19 cacophony: is there any orchestra conductor? Lancet. 2020; 395(10229):1037. DOI: https://doi.org/10.1016/S0140-6736(20)30491-8
13. Callaway E, Cyranoski D. China coronavirus: Six questions scientists are asking. Nature. 2020; 577(7792):605–607. DOI: https://doi.org/10.1038/d41586-020-00166-6
14. Wu D, Wu T, Liu Q, et al. The SARS-CoV-2 outbreak: What we know. Int J Infect Dis. 2020; 94:44–48. DOI: https://doi.org/10.1016/j.ijid.2020.03.004
15. Sebastiani G, Massa M, Riboli E. Covid-19 epidemic in Italy: evolution, projections and impact of government measures. Eur J Epidemiol. 2020; 35(4):341–345. DOI: https://doi.org/10.1007/s10654-020-00631-6
16. Holshue ML, DeBolt C, Lindquist S, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020; 382(10):929–936. DOI: https://doi.org/10.1056/NEJMoa2001191
17. Liu Е, Hu О, Xiao J, et al. Time-varying transmission dynamics of novel coronavirus pneumonia in China. [Preprint] DOI: https://doi.org/10.1101/2020.01.25.919787
18. Shlemskaya VV, Khateev AV, Prosin VI, et al. New coronavirus infection COVID-19: brief description and measures to counter its spread in Russian Federation. Meditsina Katastrof. 2020; (1):57–61. (In Russian). DOI: https://doi.org/10.33266/2070-1004-2020-1-57-61
19. Mizintseva MF, Gerbina TV, Chugrina MA. [The economy of epidemics. Impact of COVID-19 on the world economy (overview).] In: Mizintseva MF, editor. [COVID-19 Pandemic. Biology and Economics. Special Issue: Information and Analytical Collection.] Moscow: Pero Publ., 2020. Pp. 61–102. (In Russian).
20. Danilenko DM, Komissarov AB, Stukova MA, et al. To be or not to be: forecast of Covid-19 epidemic development in Russia. Zhurnal Infektologii. 2020; 12(3):6–11. (In Russian). DOI: https://doi.org/10.22625/2072-6732-2020-12-3-6-11
Review
For citations:
Ivanenko A.V., Soloviev D.V., Volkova N.A., Glinenko V.M., Smirnova O.A., Shvedova I.S., Bakhmutskaya E.V., Melnikov D.A. Epidemiological Features of the Incidence of COVID-19 in Moscow in the Period from March 1 to August 31, 2020. Public Health and Life Environment – PH&LE. 2021;(3):57-62. (In Russ.) https://doi.org/10.35627/2219-5238/2021-336-3-57-62